451 related articles for article (PubMed ID: 16109401)
1. Characterisation of imidazoline I2 binding sites in pig brain.
Anderson NJ; Lupo PA; Nutt DJ; Hudson AL; Robinson ES
Eur J Pharmacol; 2005 Sep; 519(1-2):68-74. PubMed ID: 16109401
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
[TBL] [Abstract][Full Text] [Related]
3. High-affinity binding of beta-carbolines to imidazoline I2B receptors and MAO-A in rat tissues: norharman blocks the effect of morphine withdrawal on DOPA/noradrenaline synthesis in the brain.
Miralles A; Esteban S; Sastre-Coll A; Moranta D; Asensio VJ; García-Sevilla JA
Eur J Pharmacol; 2005 Aug; 518(2-3):234-42. PubMed ID: 16061219
[TBL] [Abstract][Full Text] [Related]
4. Autoradiographic localisation of [3H]2-BFI imidazoline I2 binding sites in mouse brain.
MacInnes N; Handley SL
Eur J Pharmacol; 2005 Jun; 516(2):139-44. PubMed ID: 15925361
[TBL] [Abstract][Full Text] [Related]
5. Labelling of I2B-imidazoline receptors by [3H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) in rat brain and liver: characterization, regulation and relation to monoamine oxidase enzymes.
Alemany R; Olmos G; García-Sevilla JA
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):39-47. PubMed ID: 9228188
[TBL] [Abstract][Full Text] [Related]
6. Autoradiographical distribution of imidazoline binding sites in monoamine oxidase A deficient mice.
Anderson NJ; Seif I; Nutt DJ; Hudson AL; Robinson ES
J Neurochem; 2006 Mar; 96(6):1551-9. PubMed ID: 16476082
[TBL] [Abstract][Full Text] [Related]
7. [3H]2-(2-Benzofuranyl)-2-imidazoline, a highly selective radioligand for I2-imidazoline receptor binding sites. Studies in rabbit kidney membranes.
Hosseini AR; King PR; Louis WJ; Gundlach AL
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jan; 355(1):131-8. PubMed ID: 9007853
[TBL] [Abstract][Full Text] [Related]
8. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
Miralles A; Olmos G; Sastre M; Barturen F; Martin I; Garcia-Sevilla JA
J Pharmacol Exp Ther; 1993 Mar; 264(3):1187-97. PubMed ID: 8095548
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of amine oxidase activity by derivatives that recognize imidazoline I2 sites.
Carpéné C; Collon P; Remaury A; Cordi A; Hudson A; Nutt D; Lafontan M
J Pharmacol Exp Ther; 1995 Feb; 272(2):681-8. PubMed ID: 7853182
[TBL] [Abstract][Full Text] [Related]
10. Characterisation and localisation of [3H]2-(2-benzofuranyl)-2-imidazoline binding in rat brain: a selective ligand for imidazoline I2 receptors.
Lione LA; Nutt DJ; Hudson AL
Eur J Pharmacol; 1998 Jul; 353(1):123-35. PubMed ID: 9721049
[TBL] [Abstract][Full Text] [Related]
11. [3H]Rilmenidine-labelled imidazoline-receptor binding sites co-localize with [3H]2-(benzofuranyl)-2-imidazoline-labelled imidazoline-receptor binding sites and monoamine oxidase-B in rabbit, but not rat, kidney.
King PR; Suzuki S; Hosseini AR; Iakovidis D; Nero TL; Jackman GP; Louis WJ; Gundlach AL
J Auton Nerv Syst; 1998 Oct; 72(2-3):118-28. PubMed ID: 9851560
[TBL] [Abstract][Full Text] [Related]
12. Binding of [3H]2-(2-benzofuranyl)-2-imidazoline (BFI) to human brain: potentiation by tranylcypromine.
Wiest SA; Steinberg MI
Life Sci; 1997; 60(9):605-15. PubMed ID: 9048963
[TBL] [Abstract][Full Text] [Related]
13. [3H]2-(2-benzofuranyl)-2-imidazoline: a new selective high affinity radioligand for the study of rabbit brain imidazoline I2 receptors.
Lione LA; Nutt DJ; Hudson AL
Eur J Pharmacol; 1996 May; 304(1-3):221-9. PubMed ID: 8813605
[TBL] [Abstract][Full Text] [Related]
14. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
Alemany R; Olmos G; García-Sevilla JA
Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
[TBL] [Abstract][Full Text] [Related]
15. Nonadrenergic imidazoline binding sites on human platelets.
Piletz JE; Sletten K
J Pharmacol Exp Ther; 1993 Dec; 267(3):1493-502. PubMed ID: 8263811
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo effect of BU99006 (5-isothiocyanato-2-benzofuranyl-2-imidazoline) on I2 binding in relation to MAO: evidence for two distinct I2 binding sites.
Paterson LM; Tyacke RJ; Robinson ES; Nutt DJ; Hudson AL
Neuropharmacology; 2007 Feb; 52(2):395-404. PubMed ID: 17045310
[TBL] [Abstract][Full Text] [Related]
17. 3H[2-(2-benzofuranyl)-2-imidazoline] (BFI) binding in human platelets: modulation by tranylcypromine.
Wiest SA; Steinberg MI
Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):209-16. PubMed ID: 10494892
[TBL] [Abstract][Full Text] [Related]
18. Structural and ligand recognition properties of imidazoline binding proteins in tissues of rat and rabbit.
Lanier B; Raddatz R; Bakthavachalam V; Coupry I; Neumeyer JL; Lanier SM
Mol Pharmacol; 1995 Oct; 48(4):703-10. PubMed ID: 7476897
[TBL] [Abstract][Full Text] [Related]
19. [3H]-idazoxan binding to rabbit cerebral cortex recognises multiple imidazoline I2-type receptors: pharmacological characterization and relationship to monoamine oxidase.
Renouard A; Widdowson PS; Cordi A
Br J Pharmacol; 1993 Jul; 109(3):625-31. PubMed ID: 8102932
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of locus coeruleus neurons by non-I1/I2-type imidazoline receptors: an in vivo and in vitro electrophysiological study.
Ugedo L; Pineda J; Ruiz-Ortega JA; Martín-Ruiz R
Br J Pharmacol; 1998 Dec; 125(8):1685-94. PubMed ID: 9886760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
